PROTAGONIST THERAPEUTICS INC (PTGX) Institutional Ownership and Insiders Activity

PROTAGONIST THERAPEUTICS INC (PTGX) is widely held by institutional investors, with 365 firms reporting positions valued at approximately $9.01B based on SEC Form 13F filings for the quarter ended September 30, 2026.

Blackrock, Inc. is the largest disclosed holder, reporting approximately $1.51B in PTGX holdings in its latest filing.

Recent insider activity includes 10 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.

Institutional Holders

365

Total Reported Value

$9.01B

Largest Holder

Blackrock, Inc.

Largest Position

$1.51B

Insider Transactions (90d)

10

Latest Filing Quarter

Q3 2026

New Institutional Positions

87

Funds Exiting Positions

53